CANDESARTAN CILEXETIL tablet United States - English - NLM (National Library of Medicine)

candesartan cilexetil tablet

zydus lifesciences limited - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx) - candesartan cilexetil 4 mg - candesartan cilexetil tablets are indicated for the treatment of hypertension in adults and in children 1 to <17 years of age, to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure

APO-CANDESARTAN HCTZ 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-candesartan hctz 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 32 mg - tablet, uncoated - excipient ingredients: hyprolose; magnesium stearate; maize starch; lactose monohydrate; carmellose calcium; macrogol 8000; iron oxide yellow - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

APO-CANDESARTAN HCTZ 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-candesartan hctz 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: carmellose calcium; magnesium stearate; lactose monohydrate; macrogol 8000; hyprolose; maize starch; iron oxide red - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

ADESAN HCT 32/25 candesartan cilexetil/hydrochlorothiazide 32 mg/25 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

adesan hct 32/25 candesartan cilexetil/hydrochlorothiazide 32 mg/25 mg tablets blister pack

alphapharm pty ltd - candesartan cilexetil, quantity: 32 mg; hydrochlorothiazide, quantity: 25 mg - tablet - excipient ingredients: hyprolose; magnesium stearate; glyceryl monostearate; carmellose calcium; lactose monohydrate; maize starch; iron oxide yellow; iron oxide red - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

CANDESARTAN HCTZ AN 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

candesartan hctz an 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet bottle

amneal pharma australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: magnesium stearate; carmellose calcium; maize starch; lactose monohydrate; macrogol 8000; hyprolose; iron oxide red - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

CANDESARTAN HCTZ AN 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

candesartan hctz an 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet bottle

amneal pharma australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 32 mg - tablet, uncoated - excipient ingredients: magnesium stearate; maize starch; macrogol 8000; lactose monohydrate; carmellose calcium; hyprolose; iron oxide yellow - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

CANDESARTAN HCT GH 32/25 candesartan cilexetil 32 mg & hydrochlorothiazide 25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

candesartan hct gh 32/25 candesartan cilexetil 32 mg & hydrochlorothiazide 25 mg tablet blister pack

generic health pty ltd - candesartan cilexetil,hydrochlorothiazide -

CANDESARTAN HCT GH 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

candesartan hct gh 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet blister pack

generic health pty ltd - candesartan cilexetil,hydrochlorothiazide -

CANDESARTAN HCT GH 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

candesartan hct gh 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet blister pack

generic health pty ltd - candesartan cilexetil,hydrochlorothiazide -

CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE tablet United States - English - NLM (National Library of Medicine)

candesartan cilexetil and hydrochlorothiazide tablet

mylan pharmaceuticals inc. - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - candesartan cilexetil 16 mg - candesartan cilexetil and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with candesartan cilexetil and hydrochlorothiazide tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joi